- Develops and leads PCOA strategies to support therapeutic area /asset specific clinical development plans, value and access strategies, integrated evidence plans, and medical affairs tactics.
- Effectively collaborates with cross-functional stakeholders to ensure that the PCOA strategies and deliverables are fit for purpose and aligned with the overall program goals.
- Ensures that PCOA strategies are acceptable andcompliant with regulatory guidance (FDA, EMA).
- Conducts qualitative and quantitative research to inform COA development.
- In collaboration with Value & Evidence and R&D colleagues, develops and disseminates COA endpoint/measurement strategy.
- Provides technical expertise in the analysis, interpretation, and communication of COA data.
- Knowledge of the drug development process.
- Strong analytical and synthesis skills of qualitative and quantitative data.
- Understanding of COA research methodology and regulatory (FDA, EMA) environment
- Scientific rigor, autonomy, and sense of initiative.
- Good interpersonal and communication skills, both written and oral; ability to understand and communicate with cross-functional stakeholders.
Director, Patient-Centered Outcomes Assessment - Tadworth, United Kingdom - CK Science
Description
Director, Patient-Centered Outcomes Assessment
CK Group are recruiting for a Director of Patient Centered Outcomes Assessment to join a company in the Pharmaceutical industry at their site based in Tadworth on a contract basis for 12 months.
Salary:
Hourly £32.00-£46.10 PAYE or £35.00-£51.00 Umbrella
Director of Patient Centered Outcomes Assessment Role:
Your Background:
Company:
Our client is one of the world's premier innovative biopharmaceutical companies, discovering, developing and providing over 160 different medicines, vaccines and consumer healthcare products to help improvethe lives of millions of people in the UK and around the world every year.
Location:
This role is based at our clients site in Tadworth, however hybrid or remote may be possible for the right candidate.